Chapter 1 Chapter 1 -- chapter IMMUNIZATION AGAINST VIRAL INFECTIONS -- chapter ACTIVE SITES OF THE ANIMAL VIRUSES: POTENTIAL SITES OF SPECIFIC CHEMOTHERAPEUTIC ATTACK -- chapter THE BREADTH OF INTERFERON ACTION -- chapter INTERFERON STRUCTURE: FACTS AND SPECULATION -- chapter INTERFERON INDUCTION BY VIRUSES: MOLECULAR REQUIREMENTS -- chapter INTERFERON INDUCTION BY POLYNUCLEOTIDES -- chapter NONPOLYNUCLEOTIDEINTERFERONINDUCERS -- chapter AMANTADINE HCI AND RELATED COMPOUNDS -- chapter INHIBITION OF VIRUSES, TUMORS, AND PATHOGENIC MICROORGANISMS BY ISATIN?-THIOSEMICARBAZONE AND OTHER THIOSEMICARBAZONES -- chapter ARABINOSYL NUCLEOSIDES AND NUCLEOTIDES -- chapter 12 Chapter 12 -- chapter HALOGENATED PYRIMIDINES IN ANTIVIRAL THERAPY -- chapter ANSAMYCINS: (A) RIFAMYCIN SV DERIVATIVES -- chapter ANSAMYCINS: (B) STREPTOVARICINS -- chapter ANALOGUES OF VIRAL GENOMES.
0
I believe there is another good reason for this book. I think it will provide some direction in this growing -- sometimes awkwardly growing? field, because it is a legitimate attempt to synthesize our knowledge on antiviral compounds at several levels of organization, including their modes of action, and their activities both in animal infections and clinical medicine.